Syngene International to make additional investment in Syngene USA Inc

11 Mar 2025 Evaluate

Syngene International is all set to make an additional investment of upto $56 million in equity share capital of Syngene USA Inc (SUSA), a wholly owned subsidiary of the Company, in one or more tranches. The investment will be utilised to finance the cost of acquisition of biologics facility from Emergent Manufacturing Operations Baltimore, LLC., and for meeting the general corporate, and day-to-day operating requirements. 

The investment is expected to be completed on or before March 31, 2026 or such other date mutually agreed between the parties. There will be no change in shareholding of the Company in SUSA. SUSA will continue to remain a wholly owned subsidiary of the Company.

Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide.

Syngene Internation. Share Price

627.25 -5.70 (-0.90%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 627.25
Indegene 508.70
CMS Info Systems 334.40
Sagility 50.14
Smartworks Coworking 462.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×